Ignite Creation Date:
2025-12-24 @ 11:58 AM
Ignite Modification Date:
2025-12-25 @ 12:56 PM
Study NCT ID:
NCT05896761
Status:
COMPLETED
Last Update Posted:
2023-09-18
First Post:
2023-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants
Sponsor:
ViiV Healthcare
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-23
Completion Date Type:
ACTUAL
First Submit Date:
2023-05-31
First Submit QC Date:
None
Study First Post Date:
2023-06-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-08-22
Results First Submit QC Date:
None
Results First Post Date:
2023-09-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-22
Last Update Post Date:
2023-09-18
Last Update Post Date Type:
ACTUAL